Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?

Journal of Urology

Volumn 169, Issue 6, 2003, Pages 2113-2117

  Sweeney, Paul ^b   Millikan, Randall ^b   Donat, Machele ^b   Wood, Christopher G ^b   Radtke, Arlene Siefker ^b   Pettaway, Curtis A ^b   Grossman, H Barton ^b   Dinney, Colin P N ^b   Swanson, David A ^b   Pisters, Louis L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

Bladder; Carcinoma, transitional cell; Drug therapy; Lymph node dissection; Neoplasm metastasis

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CANCER MORTALITY; CANCER STAGING; CLINICAL ARTICLE; CYSTECTOMY; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RELAPSE; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

EID: 0038626299     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000067601.29966.4a     Document Type: Article

References (16)

1. Dimopoulos, M. A., Finn, L. and Logothetis, C. J.: Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy. J Urol, 151: 598, 1994
2. Millikan, R., Dinney, C., Swanson, D., Sweeney, P., Ro, J. Y., Smith, T. L. et al: Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol, 19: 4005, 2001
3. Hellsten, S., Rintala, E., Wahlqvist, R. and Malmstrom, P. U.: Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group. Eur Urol, suppl., 33: 35, 1998
4. Stöckle, M., Meyenburg, W., Wellek, S., Voges, G. E., Rossmann, M., Gertenbach, U. et al: Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol, 153: 47, 1995
5. Skinner, D. G., Daniels, J. R., Russell, C. A., Lieskovsky, G., Boyd, S. D., Nichols, P. et al: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol, 145: 459, 1991
6. Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Geller, N., Herr, H. W. et al: Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer, 64: 2448, 1989
7. Laplante, M. and Brice, M., II: The upper limits of hopeful application of radical cystectomy for vesical carcinoma: does nodal metastasis always indicate incurability? J Urol, 109: 261, 1973
8. Smith, J. A., Jr. and Whitmore, W. F., Jr.: Regional lymph node metastasis from bladder cancer. J Urol, 126: 591, 1981
9. Dodd, P. M., McCaffrey, J. A., Herr, H., Mazumdar, M., Bacik, J., Higgins, G. et al: Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. J Clin Oncol, 17: 2546, 1999
10. Slaton, J. W., Swanson, D. A., Grossman, H. B. and Dinney, C. P. N.: A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J Urol, 162: 710, 1999
11. AJCC Cancer Staging Manual, 5th ed. Edited by I. D. Fleming, J. S. Cooper, D. E. Henson, R. V. P. Hutter, B. J. Kennedy, G. P. Murphy et al. Philadelphia: Lippincott-Raven, 1997
12. Stein, J. P., Lieskovsky, G., Cote, R., Groshen, S., Feng, A. C., Boyd, S. et al: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol, 19: 666, 2001
13. Mills, R. D., Turner, W. H., Fleischmann, A., Markwalder, R., Thalmann, G. N. and Studer, U. E.: Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol, 166: 19, 2001
14. Vieweg, J., Gschwend, J. E., Herr, H. W. and Fair, W. R.: Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol, 161: 449, 1999
15. Herr, H. W. and Donat, S. M.: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol, 165: 62, 2001
16. Herr, H. W., Donat, S. M. and Bajorin, D. F.: Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. J Urol, 165: 811, 2001